Literature DB >> 30719936

Incremental utility of an extended stroop task for identifying subtle differences in cognitive performance among healthy older adults.

Lauren M D Faulkner1, Kathryn A Tolle2, Carrington R Wendell1, Shari R Waldstein1, Leslie I Katzel3,4, Robert J Spencer1,2.   

Abstract

The Stroop Color and Word Test is a test of processing speed, response inhibition, and executive functioning (EF). This project examined whether extending the Stroop Color-Word trial beyond the standard time limit could more accurately assess performance on EF measures. Cognitively healthy older individuals (n = 198) enrolled in a study of cardiovascular health completed the Stroop as part of a neuropsychological battery. Two scores were computed for the Color-Word trial: the number of items completed within the first 45 seconds (traditional Color-Word score) and the speed of page completion beyond the first 45 seconds (Stroop-Extended score). Criterion measures included the Trail-Making Test Part B (TMT-B), Digit Span Backward, Symbol Digit Modalities Test, Short Category Test, and measures of verbal fluency. Results from hierarchical linear regression analyses indicated that the extended Stroop score accounted for small but statistically significant variance in TMT-B (additional 2.6%) and Digit Span Backwards (additional 2.6%) beyond the standard Color-Word score. These findings suggest that extending the Stroop Color-Word trial beyond the first 45 seconds provides a limited increase in predictive power within a healthy sample with restricted range of performance. The extended Stroop requires additional examination in heterogeneous samples, including clinical populations, to determine its predictive utility.

Entities:  

Keywords:  Executive Functioning; Neuropsychological Assessment; Processing Speed; Psychometrics; Stroop Color Word Test

Mesh:

Year:  2019        PMID: 30719936      PMCID: PMC6682470          DOI: 10.1080/23279095.2019.1565763

Source DB:  PubMed          Journal:  Appl Neuropsychol Adult        ISSN: 2327-9095            Impact factor:   2.248


  20 in total

1.  Improving the ecological validity of executive functioning assessment.

Authors:  Naomi Chaytor; Maureen Schmitter-Edgecombe; Robert Burr
Journal:  Arch Clin Neuropsychol       Date:  2006-03-22       Impact factor: 2.813

2.  Effect of test duration on age-related differences in Stroop interference.

Authors:  M Klein; R W Ponds; P J Houx; J Jolles
Journal:  J Clin Exp Neuropsychol       Date:  1997-02       Impact factor: 2.475

Review 3.  Selective review of cognitive aging.

Authors:  Timothy A Salthouse
Journal:  J Int Neuropsychol Soc       Date:  2010-08-02       Impact factor: 2.892

4.  Specific impairments of planning.

Authors:  T Shallice
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1982-06-25       Impact factor: 6.237

5.  A short form of the Category Test for adults.

Authors:  R J Gregory; J J Paul; M W Morrison
Journal:  J Clin Psychol       Date:  1979-10

Review 6.  Executive functions.

Authors:  Adele Diamond
Journal:  Annu Rev Psychol       Date:  2012-09-27       Impact factor: 24.137

7.  Stroop performance in focal lesion patients: dissociation of processes and frontal lobe lesion location.

Authors:  D T Stuss; D Floden; M P Alexander; B Levine; D Katz
Journal:  Neuropsychologia       Date:  2001       Impact factor: 3.139

8.  Assessment practices of clinical neuropsychologists in the United States and Canada: a survey of INS, NAN, and APA Division 40 members.

Authors:  Laura A Rabin; William B Barr; Leslie A Burton
Journal:  Arch Clin Neuropsychol       Date:  2005-01       Impact factor: 2.813

9.  The Tower of London and neuropsychological assessment of ADHD in adults.

Authors:  Cynthia A Riccio; Monica E Wolfe; Cassandra Romine; Brandon Davis; Jeremy R Sullivan
Journal:  Arch Clin Neuropsychol       Date:  2004-08       Impact factor: 2.813

10.  A brief assessment of executive control dysfunction: discriminant validity and homogeneity of planning, set shift, and fluency measures.

Authors:  K R Hanes; D G Andrewes; D J Smith; C Pantelis
Journal:  Arch Clin Neuropsychol       Date:  1996       Impact factor: 2.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.